Overview
Status
Active
Registry date
2002-01-16
Share capital
5,000.00 PLN
Registered address
ul. Świętokrzyska 30/63, 00-116 Warszawa, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2021 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 196 days for 2020).
- 2021not filed
- 202029/04/2022
- 201921/02/2021
- 201830/09/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Jerzy Marian Repeta – President of the Management Board
Manner of representation
Each member of the management board independently; a commercial proxy independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mina Ag | 50 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2003-12-31 to 2025-06-27.
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 10, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| LASTsp. z o.o. | – | last-skincare.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-12-30 | Address change (Świętokrzyska 36/30/29, 00-116, Warszawa → Ul. Świętokrzyska 30/63, 00-116, Warszawa) | |
| 2011-09-08 | Address change (Jagiellońska 46/15, 03-462, Warszawa → Świętokrzyska 36/30/29, 00-116, Warszawa) | |
| 2010-11-04 | Share capital increase (4,000.00 PLN → 5,000.00 PLN) | |
| 2010-11-04 | Name change ("a & J" → Dermin) | |
| 2002-01-16 | Entered in the register |
FAQ
The main business activity of Dermin focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on January 16, 2002.
The headquarters is located at: ul. Świętokrzyska 30, 00-116 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.
The company reported a revenue of −$415 in 2019, which is an increase of 84.3% compared to 2018.
No, the company recorded a net loss of $5,003 in 2019. For comparison, in 2018 the loss was $115,480, meaning the company reduced its loss by 95.4%.
The largest operating cost category falls under external services. This category amounted to $599 in 2019, representing 47% of all operating expenses.
Last updated: 2026-10-07